Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
Both the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) and the iShares Biotechnology ETF (NASDAQ:IBB)target specific niches of the healthcare sector, but their distinct approaches could appeal to different investors.
While IBB casts a wide net across hundreds of biotech companies, PJP focuses on a tight group of 30 pharmaceutical companies involved in drug development and distribution. Here’s how the two stack up on risk, reward, and other factors that might influence your decision between the two.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.